Advertisement

Topics

Popular Biotech News, Healthcare News and Pharma News

06:27 EDT 28th September 2016 | BioPortfolio

Training on 2017 ICD-10 Otolaryngology, Urology & Gastroenterology Coding Updates at AudioEducator

AudioEducator will host a series of audio conferences in the month of September 2016, highlighting the changes that have been updated in the existing ICD-10 coding manual for 2017. These audio conferences will be presented by leading healthcare coding experts in otolaryngology, urology and gastroenterology. Durham, NC (PRWEB) September 21, 2016 AudioEducator is a leading source of knowledge, info...

Meaningful Use gets a meaningful change: 90-day reporting

The Centers for Medicare and Medicaid Services (CMS) have issued a proposed change making Meaningful Use more flexible for physicians by allowing them to report only for a 90-day period in 2016. Also included in the change is a hardship exemption for first time Meaningful Use participants to report once in 2017 to satisfy both Meaningful Use and the Advanced Care Information (ACI) performance ca...

Cerulean Pharma (CERU) - Termination of coverage

Edison Investment Research - Pharmaceutical & healthcare - Cerulean Pharma: Edison Investment Research is terminating coverage on Cerulean Pharma (CERU). Please note you should no longer rely on any previous research or estimates for this company. All forecasts should now be considered redundant. ISIN: US15708Q1058

Thomas Eye Group Among the First in U.S. to Implant New Tecnis Symfony® Intraocular Lenses to Treat Cataracts, Improve Extended Range of Vision

The Tecnis Symfony® Intraocular Lense sharpen vision for patients with presbyopia and astigmatism, diminishing the need for contacts and eye glasses Atlanta, Georgia (PRWEB) September 21, 2016 Thomas Eye Group, a leading metro Atlanta eye care provider that offers comprehensive services including LASIK and medical, surgical and cosmetic eye care, announced today that it is among the first op...

ViiV Healthcare starts phase 3 for HIV treatment

ViiV Healthcare launches phase III programme evaluating a two-drug regimen combining Dolutegravir and Lamivudine for HIV-1 treatment. The post ViiV Healthcare starts phase 3 for HIV treatment appeared first on PharmaAsia.

FMC Health and Nutrition to Exhibit at Supply Side West 2016

FMC will showcase solutions for the pharmaceutical, nutraceutical and nutrition industries, and announce a new product innovation PHILADELPHIA, Pa (PRWEB) September 27, 2016 FMC Corporation’s Health and Nutrition business announced today it will showcase solutions for a stronger, more effective tablet and capsule, ingredients that enable the perfect gummie and concentrations of Omega-3 at this ...

NovaBiotics’ Lynovex® Gains Support From The UK’s Cystic Fibrosis Trust

        Aberdeen and London, UK – 30 October 2013 – NovaBiotics Ltd, the clinical-stage biotechnology company, today announced that it has partnered with the Cystic Fibrosis Trust and Health Sciences Scotland, for a Phase1/2a clinical trial of its novel compound, Lynovex®.  Lynovex is being developed as a treatment for persistent lung infection in cys...

Merck Sells Arecibo Plant to AIAC

AIAC will retain the approximately 200 Merck employees at the manufacturing facility at Arecibo, Puerto Rico.

Otrivine Mu-Cron discontinued

Novartis has discontinued Otrivine Mu-Cron (paracetamol, pseudoephedrine hydrochloride) with immediate effect.

World Congress Announces Agenda for The 340B Summit

Boston, MA, March 22, 2016 --(PR.com)-- World Congress has announced the agenda for The 340B Summit taking place at the Hilton Philadelphia at Penn’s Landing in Philadelphia. Covered entities will gather at this inaugural event to determine the impact of revised mega-guidance, discuss strategies for managing compliance, and evaluate the financial risks and opportunities of the 340B program....

FLX Bio raises $29mm in Series A round

FLX Bio Inc. raised $29mm through its Series A round. The company was recently formed by shareholders of Flexus Biosciences, which was bought by Bristol-Myers Squibb for a total consideration of $1.25bn. BMS is interested in Flexus' IDO1 inhibitor F001287 and IDO/TDO discovery program, and is not taking on remaining non-IDO/TDO assets of Flexus including those related to a Phase 1 FLT3 and CDK4/6 ...

Bruker Launches rapifleX MALDI PharmaPulse Solution for uHTS

SAN ANTONIO, June 6, 2016 /PRNewswire/ -- At the 64th ASMS Conference, Bruker announces the launch of the new rapifleX™ MALDI PharmaPulse™ (MPP) solution.  It is the latest addition to Bruker's portfolio of innovative products designed to assist pharmaceutical, biotech and CRO customers to accelerate drug discovery, and rapifleX MPP can dramatically lower the cost of ultra-hi...

AVIE! MedSpa and Laser Center in Leesburg, VA Now Offering PRP Hair Restoration

PRP hair restoration is the newest hair loss solution offered at AVIE! MedSpa and Laser Center. Leesburg, Virginia (PRWEB) July 20, 2016 AVIE! MedSpa and Laser Center is proud to introduce PRP hair restoration, the safe and effective hair loss solution that has worked wonders for men and women all over the country. This groundbreaking non-surgical treatment counteracts hair that is balding or thi...

Deaths: Michele Stewart Caldwell

On 27 July 2016, Michele Stewart Caldwell FRPharmS, aged 60, of Kilmarnock, Ayrshire. Mrs Caldwell registered with the Society in 1980 and was made a Fellow in May 2016. Mrs Caldwell was director of pharmacy for NHS Ayrshire and Arran for 12 years. She retired in April 2016. 

Auritec Pharmaceuticals Announces Opening of Clinical Trial in Arthritis

Auritec Pharmaceuticals, Inc., an emerging drug delivery biotech, is proud to confirm that EP-104IAR, a sustained release injectable formulation for treatment of pain associated with osteoarthritis (OA), has entered a registered Phase I clinical trial. The clinical trial, which has Health Canada CTA approval, will be conducted across two sites in London, Ontario, Canada. Santa Monica, CA (PRWEB) A...

Lung Institute Hosts New COPD Treatment Seminar in Knoxville, Offering On-Site Consultations

Jack Coleman, Jr., M.D., will present an informative seminar for people with chronic lung diseases, August 9th at the University of Tennessee. Tampa, Fla. (PRWEB) August 02, 2016 The Lung Institute will host a seminar at the University of Tennessee in Knoxville on August 9 to inform people with chronic lung diseases on the benefits of stem cell therapy for lung disease. Jack Coleman, Jr., M.D., w...

[Comment] Mass trapping of malaria vector mosquitoes

Every field of research needs a few pleasant surprises every now and then to challenge the limitations imposed by existing paradigms, and stretch the ambitions of those of us who accepted them for too long. In The Lancet, Tobias Homan and colleagues1 show that population-wide installation of solar-powered odour-baited mosquito traps beside houses in Rusinga Island (Lake Victoria, western Kenya, Af...

The 4th World Parkinson Congress Presents Its First Art Walk in Portland

For the first time ever, the WPC will have its own Art Walk, showcasing art by members of the Parkinson's community. New York, NY (PRWEB) August 24, 2016 From September 20 to 23, Portland is going to be Parkinson’s ready as it greets more than 4,000 participants in this year’s triennial meeting of the World Parkinson Congress (WPC 2016). Part of the WPC experience includes an “Art Walk...

Shionogi Presents Results from a Phase 2 Proof-of-Concept Clinical Trial and Non-Clinical Studies of S-033188, a Novel Cap-Dependent Endonuclease Inhibitor for Treatment of Influenza

OSAKA, Japan, Aug. 28, 2016 /PRNewswire/ -- Shionogi & Co., Ltd. (hereafter "Shionogi") reported clinical and non-clinical data for S-033188, a cap-dependent endonuclease inhibitor targeting influenza. In a Phase 2 proof-of-concept study, one-day, single oral dose of S-033188 demonstrated favorable safety and efficacy results that support moving forward into a global Phase 3 program. Thes...

RÉGIME MÉDITERRANÉEN: Il évite le décès à un patient cardiaque sur 3 - ESC Cardio

Finalement le régime méditerranéen pourrait éviter à de nombreux patients cardiaques un événement sévère entraînant une mort subite, démontre cette étude menée chez des patients à antécédents de maladie cardiovasculaire, présentée au Congrès de l'European Society of C...

Paralyzed Veterans of America Weighs in on Presidential Candidates' Positions

WASHINGTON, Sept. 2, 2016 /PRNewswire/ -- Paralyzed Veterans of America (Paralyzed Veterans) is responding to remarks made this week by presidential candidates Donald Trump and Hillary Clinton at the American Legion's annual convention.  The most recent remarks indicate the two candidates are more closely aligned on their positions to reform VA health care to sustain the system of care m...

Agenda @Biotech Week Boston: WHERE THE HEART, TECHNOLOGY AND BUSINESS OF SCIENCE CONVERGE, Conference: October 4 – 7, 2016 | Exhibition: October 5-7, 2016 Boston Convention and Exhibition Center

Agenda @Biotech Week Boston: WHERE THE HEART, TECHNOLOGY AND BUSINESS OF SCIENCE CONVERGE, Conference: October 4 – 7, 2016 | Exhibition: October 5-7, 2016 Boston Convention and Exhibition Center Reporter: Aviva Lev-Ari, PhD, RN Conference: October 4 – 7, 2016 | Exhibition: October 5-7, 2016 Boston Convention and Exhibition Center, Boston, MA WHERE THE HEART, […]

Futura shares double after successful clinical trial

Shares in Futura Medical PLC (LON:FUM) doubled in value after the company announced a pivotal clinical trial of its gel for erectile dysfunction (ED) had been a resounding success. It means Futura now has a differentiated product in a market worth US$5bn that , currently dominated by top-selling drugs, such as Viagra and Cialis, that have limitations. City broker N+1 Singer said it thought the...

Star-shaped polymers to kill superbugs

Researchers have developed tiny, star-shaped molecules that can apparently kill superbugs — bacteria that are no longer affected by current antibiotics. The star-shaped structures are short chains of proteins called ‘peptide polymers’ and were created by a team from the University of Melbourne and the University of South Australia. “These new synthetic antibiotics (SNAPPs) are modelled on...

‘Bridget Jones’s Baby’ Puts Spotlight on Demand for Paternity Testing

IDENTIGENE, America's #1 paternity-test brand, says 100,000 at-home kits are sold in the U.S. each year. Salt Lake City, UT. (PRWEB) September 14, 2016 The new major motion picture Bridget Jones’s Baby, set to release in the United States on September 16, is (of course) about Bridget—a lovable woman-next-door who is pregnant and isn’t sure which of her two suitors is the father of her b...

South Asia Biotechnology Centre Invites Public Comments to Support GE Mustard

The South Asia Biotechnology Centre (SABC) is inviting the public to submit comments in favor of the barnase-barstar technology and genetically engineered (GE) mustard hybrid DMH-11 to the Indian Ministry of Environment, Forest and Climate Change (MOEF). The barnase-barstar technology and GE mustard hybrid DMH-11, rigorously assessed for biosafety ...

Six Children’s Hospitals Unite to Improve Pediatric Health

Sanford Children’s Genomic Medicine Consortium integrates genomic care, advances research, educational efforts. Sioux Falls, SD (PRWEB) September 14, 2016 Six founding children’s hospitals have signed an agreement to form the Sanford Children’s Genomic Medicine Consortium, a cutting-edge collaboration of children’s hospitals inspired by the vision of philanthropist Denny Sanford. Foundin...

Largest Powerboat Show in Years Heads to Annapolis: More Than 300 Boats

The largest powerboat show in years is coming to Annapolis, October 13-16, 2016 and attendees will shop among 330 boats and more than 100 center consoles. Sponsored by the Annapolis Boat Shows, grand prizes include a 17 foot Edgewater powerboat and a MarineMax BVI Charter. Annapolis, Maryland (PRWEB) September 15, 2016 The United States Powerboat Shows is coming to Annapolis, Maryland October 13-...

New Interception Dream Team Announced to Research Opportunities to Detect Early and Intercept Development of Lung Cancer Cells to Save Lives

American Lung Association Extends Lung Cancer Research Investment with Interception Dream Team in Collaboration with Stand Up To Cancer and LUNGevity Foundation (PRWEB) September 15, 2016 The American Lung Association and its LUNG FORCE initiative has announced it is expanding its investment in lung cancer research through a new collaboration with Stand Up To Cancer and LUNGevity Foundation, to c...

Obesity: The fat advantage

Obese people have a higher incidence of kidney cancer, but are also more likely to survive the disease. Is the 'obesity paradox' real or an artefact of how studies are conducted?

Carolinas Hospital Joins Mayo Clinic Care Network: 5 Things to Know

On Wednesday,  Carolinas Hospital System and Mayo Clinic announced that Carolinas Hospital System has joined the Mayo Clinic Care Network of independent health care providers committed to working together to benefit patients and their families. Here are five things to know about the collaboration:  1. As part of the network, Carolinas Hospital System physicians will have access to Mayo C...

Novavax RSV F Vaccine Fails Phase III Trial

Novavax acknowledged that its RSV F-protein recombinant nanoparticle vaccine candidate failed a Phase III trial, sending the company’s shares crashing by more than three-quarters in after-hours trading. RSV F Vaccine missed its primary and secondary efficacy endpoints in the Phase III Resolve trial, in which the vaccine was given to 11,856 adults aged 60 and older. The trial’s pr...

NYC Dermatologist Bobby Buka's New Eye-Catching Subway Advertisements

NEW YORK, Sept. 16, 2016 /PRNewswire/ -- Dr. Bobby Buka has just launched a collection of eye-catching and provocative advertisements in the subway trains throughout New York City to promote his five Dermatology locations (Greenwich Village, Front Street, Upper West Side, Williamsburg & Crown Heights), his Practice's focus on medical conditions, as well as cosmetic, and his unique and dif...

Mesothelioma Survivor on Keytruda Tells His Story of Perseverance to Surviving Mesothelioma

A Maine man diagnosed with pleural mesothelioma more than three years ago is doing well after rejecting conventional treatments and seeking his own path toward survival. Raleigh, NC (PRWEB) September 19, 2016 Jim McHutchison of York, Maine was told he had less than a year to live when he was diagnosed with rare malignant pleural mesothelioma in 2013. But in a recent interview with Surviving Mesot...

Deadline Nears for 2016 HREI Insights Awards™

Entries are due Friday, Sept. 30, 2016, for the fourth annual awards recognizing excellence in healthcare real estate development and executive leadership MINNEAPOLIS (PRWEB) September 19, 2016 The deadline is fast approaching to submit entries to the 2016 HREI Insights Awards™. The last day to submit entries to the only comprehensive national awards program totally dedicated to recognizing exc...

Alopecia Areata Awareness Month: New Treatment Utilizes 3D-Printing Technology

Top hair loss expert and new treatment pioneer, Dr. Alan J. Bauman, discusses how new hair and scalp cranial prosthetic hair replacements made with 3D-printing are offering new hope to alopecia sufferers. Boca Raton, Florida (PRWEB) September 20, 2016 September is National Alopecia Areata Awareness Month and it’s an important opportunity for those suffering from alopecia areata and other less c...

Dermatologists give views on impact of Eli Lilly’s Taltz and Novartis’ Cosentyx

Taltz (ixekizumab), a monoclonal antibody (MOA) from US pharma major Eli Lilly, and Swiss pharma giant…

Sanofi's MS drug Lemtrada still effective five years after last treatment

Sanofi has published six-year investigational data on its Multiple Sclerosis (MS) drug Lemtrada (alemtuzumab)…

Pharmacists: Caring for you!

'Pharmacists: caring for you' is the theme of this year's 'pharmacists day' which falls on 25th September 2016.

Mesoblast (MSB) - Tightening focus to extend runway

Edison Investment Research - Pharmaceutical & healthcare - Mesoblast: Mesoblast cut its cash burn by 15% in FY16 to US$90m, and guided for a further ~25% reduction in FY17, which will give it headroom to fund the Phase III heart failure (HF) trial that Teva relinquished in June. It has ~12 months of cash runway plus a US$90m equity finance facility, which will give a further 12 months’ runwa...

MediSend, Liberia’s Ministry of Health and the World Health Organization Partner to Help Rebuild Liberian Healthcare Infrastructure

MediSend is training three Liberian biomedical engineering technicians, sponsored by the Ministry of Health and the World Health Organization, as part of a healthcare reconstruction and strengthening plan following the devastating effects of the Ebola outbreak in 2014. The technicians will play a major role in Liberia’s national support system, acting as mentors/trainers for future biomedical en...

Single crystal measures radioactivity

A research team at Empa and ETH Zurich has developed single crystals made of lead halide perovskites, which are able to gage radioactive radiation with high precision. Initial experiments have shown that these crystals, which can be manufactured from aqueous solutions or low-priced solvents, work ju...

CareMore Appoints Dynamic Clinical Leadership Team In Memphis

MEMPHIS, Tenn., Sept. 21, 2016 /PRNewswire/ -- CareMore Health System has named Dr. Mark David Harris as regional medical officer to lead patient care and clinical operations; Dr. Sandeep Palakodeti as chief of hospital medicine; and Dr. Manisha A. Sharma as director of community health and primary care in Shelby County. In his role as regional medical officer, Dr. Harris will be responsible for ...

Anti-GMO activists can’t admit success of Bangladesh’s insect-resistant GMO eggplant

For more than a decade controversy has raged in the world’s media about whether genetically engineered crops are dangerous, as many environmentalists have long claimed. Yet… a quiet revolution has been unfolding… In Bangladesh, thousands of smallholder farmers are… successfully growing the world’s first GM food crop expressly developed for poorer countries. Indonesia is not ...

Gay Parents To Be Will Participate at Men Having Babies Conference in Brussels, Belgium

Mark Leondires, M.D., and Genetic Counselor James Speer, M.S., LCGC, Will Conduct In-Person Consultations about Surrogacy Norwalk, CT (PRWEB) September 22, 2016 Gay Parents To Be (GPTB) at Reproductive Medicine Associates of Connecticut (RMACT) will be participating at the Men Having Babies (MHB) Conference in Brussels, Belgium from September 24 – 25, 2016. During the Conference, attendees will...

NICE backs Gilead’s hepatitis C drug Epclusa

The National Institute for Health and Care Excellence (NICE) thas recommended Epclusa (sofosbuvir-velpatasvir),…

FDA Panel Supports Class II For Wound Dressings, But More Controls When Antibiotics Are Added

Most experts on US FDA’s General & Plastic Surgery Devices Advisory Committee recommended Sept. 21 that drug-containing wound dressings should...      Related StoriesDeadline Reprieve Mooted For Russian Registration ReplacementsChina VC Watch: Genome, Diagnostics Ventures Attract New FundingMedtronic Artificial Pancreas Trial Results Published 

FountainVest Raises $2.1 Billion for Third China PE Fund

FountainVest Partners, a China private equity investor, closed its third fund, FountainVest China Capital Partners Fund III, L.P., with $2.1 billion of committed capital. Healthcare and pharmaceuticals are an important sector for FountainVest. The firm said the fund was oversubscribed, with support from existing investors and new international global institutional investors. FountainVest seek...

Alexion Employees Volunteer Together in Company’s First Global Day of Service

Friday, September 23rd 2016 at 10:30am UTC More than 1,500 Alexion employees in 30 communities take part in community service projects focused on improving health, wellness, and education NEW HAVEN, Conn.–(BUSINESS WIRE)– Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that more than 1,500 employees around the world are volunteering in their respective communities as part o...

Quick Search
Advertisement